Beta Bionics priced an upsized IPO at $17 per share with expected gross proceeds of $204 million

From GlobeNewswire: 2025-01-29 22:34:27

Beta Bionics, Inc. priced its upsized initial public offering of 12,000,000 shares of common stock at $17.00 per share, expecting gross proceeds of $204.0 million. The offering includes a 30-day option for underwriters to purchase up to an additional 1,800,000 shares. The shares will trade on Nasdaq under the ticker symbol “BBNX.” BofA Securities, Piper Sandler, and Leerink Partners are lead bookrunners. Beta Bionics also agreed to sell 1,000,000 shares in a private placement, totaling expected gross proceeds of $221.0 million. The offering is subject to customary closing conditions and SEC regulations.



Read more at GlobeNewswire: Beta Bionics Announces Pricing of Upsized $204 Million